CTRI/2018/08/015559尚未招募未知
â??Establishment of national gall bladder cancer registryâ??
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •All Patients with biopsy proven histopathology of adenocarcinoma gall bladder
排除标准
- •Patients unwilling to participate in the study
研究者
相似试验
尚未招募
不适用
A trial to increase participation in the National Bowel Cancer Screening Program by eligible Indigenous clients of participating primary health care centres that receive either an intensive model of support or a low intensity model of support in offering screening.ACTRN12618001555246Menzies School of Health Research900
招募中
不适用
Kidney cancer treatment & outcome study.CTRI/2012/11/003147Indian Cooperative Oncology Network100
进行中（未招募）
不适用
Detection of bladder cancer using a fluorescent dye (PVP-Hypericin)Suspected non-muscle invasive (superficial) bladder cancerMedDRA version: 17.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-001819-30-DESanochemia Pharmazeutika AG220
进行中（未招募）
不适用
Detection of bladder cancer using a fluorescent dye (PVP-Hypericin)Suspected non-muscle invasive (superficial) bladder cancerMedDRA version: 17.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-001819-30-ATSanochemia Pharmazeutika AG220
已完成
2 期
Detection of non-muscle invasive bladder cancer using PVP-Hypericin (Vidon®) fluorescence cystoscopy(Hypericin PDD)C67Malignant neoplasm of bladderDRKS00003324Sanochemia Pharmazeutika AG227